Search results
FDA OKs first menthol e-cigarettes, citing potential to help adult smokers
Associated Press via AOL· 3 days agoThe Food and Drug Administration on Friday authorized menthol-flavored electronic cigarettes for adult smokers, the government’s strongest indication yet ...
Menthol-flavored e-cigarettes get greenlight by FDA
FOX 2 News Detroit· 2 days agoThe FDA has approved marketing for menthol flavored e-cigarettes, to help people quit smoking. FOX 2 (WJBK) - On Friday the FDA approved menthol-flavored...
Cadrenal drug moving closer to FDA approval | Jax Daily Record
Jacksonville Daily Record· 4 days agoCadrenal Therapeutics Inc. is closing in on seeking U.S. Food and Drug Administration approval for its anticoagulant drug called tecarfarin ...
FDA OKs first menthol e-cigarettes
Axios· 2 days agoThe Food and Drug Administration on Friday authorized the sale of the first menthol e-cigarettes for adults, saying evidence showed they could reduce the ...
FDA OKs first menthol e-cigarettes
The Florence Times-Daily· 2 days agoWASHINGTON — The Food and Drug Administration on Friday authorized the first menthol-flavored electronic cigarettes for adult smokers, acknowledging that...
FDA Warns of Contaminated Oysters and Clams | Newswise
Newswise· 4 days agoThe Food and Drug Administration says shellfish from a number of states could be contaminated with toxins that cause paralytic shellfish poisoning. Paralytic ...
FDA OKs first menthol e-cigarettes
Fortune· 2 days agoThe FDA said it authorized four menthol e-cigarettes from Njoy, the vaping brand recently acquired by tobacco giant Altria, which also sells Marlboro cigarettes. All the e-cigarettes ...
Jimmy Carter's long stay in hospice dispels myths about end-of-life care - UPI.com
UPI· 25 minutes ago1 of 3 | Former President Jimmy Carter departs after the funeral service for former first lady Rosalynn Carter at Maranatha Baptist Church on November. NEW YORK, June 24 (UPI) -- Former President ...
Sarepta Therapeutics surges 32% on expanded FDA approval for Duchenne gene therapy
Investing.com via Yahoo Finance· 3 days agoInvesting.com - Sarepta Therapeutics (NASDAQ:SRPT), a pioneer in precision genetic medicine for rare diseases, surged sharply following the market open on Friday after receiving extended approval ...
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
InvestorPlace· 3 days agoSarepta Therapeutics (NASDAQ:SRPT) stock jumped about 30% overnight after the Food and Drug ...
